Back
Heron Therapeutics Stock Price Chart
Sponsored
HRTX
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Sell
29
HRTX
Heron Therapeutics
Last Price:
2.35
Seasonality Move:
8.75%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRTX is experiencing slight selling pressure.
Heron Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.56 | Sell |
20-day SMA: | 2.7 | Sell |
50-day SMA: | 2.72 | Sell |
200-day SMA: | 1.8 | Buy |
8-day EMA: | 2.54 | Sell |
20-day EMA: | 2.65 | Sell |
50-day EMA: | 2.63 | Sell |
200-day EMA: | 2.19 | Buy |
Heron Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 35.89 | Sell |
Chaikin Money Flow: | -1099692 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.54 - 2.86) | Sell |
Bollinger Bands (100): | (1.97 - 2.85) | Sell |
Heron Therapeutics Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.32 while HRTX 8-day simple moving average is 2.56, which is a Sell signal.
- The stock price of HRTX is 2.32 while Heron Therapeutics 20-day SMA is 2.70, which makes it a Sell.
- Heron Therapeutics 50-day simple moving average is 2.72 while HRTX share price is 2.32, making it a Sell technically.
- HRTX stock price is 2.32 and Heron Therapeutics 200-day simple moving average is 1.80, creating a Buy signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
29
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a Sell
The current Heron Therapeutics [HRTX] share price is $2.32. The Score for HRTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
348.76M
Price in USD:
2.32
Share Volume:
2.32M
Heron Therapeutics 52-Week Range
52-Week High:
3.22
52-Week Low:
0.50
Sell
29
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?
The Heron Therapeutics stock price is 2.32 USD today. -
Will HRTX stock go up or go down?
Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Heron Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.32 while HRTX 8-day exponential moving average is 2.54, which is a Sell signal.
- The stock price of HRTX is 2.32 while Heron Therapeutics 20-day EMA is 2.65, which makes it a Sell.
- Heron Therapeutics 50-day exponential moving average is 2.63 while HRTX share price is 2.32, making it a Sell technically.
- HRTX stock price is 2.32 and Heron Therapeutics 200-day simple moving average is 2.19, creating a Buy signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.20 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
- HRTX Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Heron Therapeutics is a Sell
- Heron Therapeutics Relative Strength Index (RSI) is 35.89, which suggest Heron Therapeutics is oversold
- The Bollinger Bands (25) for Heron Therapeutics is (2.54 - 2.86), which suggest Heron Therapeutics is a Sell
- The Bollinger Bands (100) for Heron Therapeutics is (1.97 - 2.85), which suggest Heron Therapeutics is a Sell
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.